Teshima T - Search Results

1

Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

Aoyama K, Saha A, Tolar J, Riddle MJ, Veenstra RG, Taylor PA, Blomhoff R, Panoskaltsis-Mortari A, Klebanoff CA, Socié G, Munn DH, Murphy WJ, Serody JS, Fulton LM, Teshima T, Chandraratna RA, Dmitrovsky E, Guo Y, Noelle RJ, Blazar BR. Aoyama K, et al. Among authors: teshima t. Blood. 2013 Sep 19;122(12):2125-34. doi: 10.1182/blood-2012-11-470252. Epub 2013 Jun 27. Blood. 2013. PMID: 23814022 Free PMC article.

2

Understanding the alloresponse: new approaches to graft-versus-host disease prevention.

Teshima T, Ferrara JL. Teshima T, et al. Semin Hematol. 2002 Jan;39(1):15-22. doi: 10.1053/shem.2002.29246. Semin Hematol. 2002. PMID: 11799525 Review.

3

Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease.

Teshima T, Reddy P, Lowler KP, KuKuruga MA, Liu C, Cooke KR, Ferrara JL. Teshima T, et al. Blood. 2002 Mar 1;99(5):1825-32. doi: 10.1182/blood.v99.5.1825. Blood. 2002. PMID: 11861301 Free article.

4

Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.

Ordemann R, Hutchinson R, Friedman J, Burakoff SJ, Reddy P, Duffner U, Braun TM, Liu C, Teshima T, Ferrara JL. Ordemann R, et al. Among authors: teshima t. J Clin Invest. 2002 May;109(9):1249-56. doi: 10.1172/JCI14793. J Clin Invest. 2002. PMID: 11994414 Free PMC article.

5

Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation.

Reddy P, Teshima T, Hildebrandt G, Duffner U, Maeda Y, Cooke KR, Ferrara JL. Reddy P, et al. Among authors: teshima t. Blood. 2002 Nov 1;100(9):3429-31. doi: 10.1182/blood-2002-04-1252. Blood. 2002. PMID: 12384449 Free article.

6

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.

Reddy P, Teshima T, Hildebrandt G, Williams DL, Liu C, Cooke KR, Ferrara JL. Reddy P, et al. Among authors: teshima t. Blood. 2003 Apr 1;101(7):2877-85. doi: 10.1182/blood-2002-08-2566. Epub 2002 Nov 14. Blood. 2003. PMID: 12433681 Free article.

7

Impaired thymic negative selection causes autoimmune graft-versus-host disease.

Teshima T, Reddy P, Liu C, Williams D, Cooke KR, Ferrara JL. Teshima T, et al. Blood. 2003 Jul 15;102(2):429-35. doi: 10.1182/blood-2003-01-0266. Epub 2003 Mar 27. Blood. 2003. PMID: 12663438 Free article.

8

Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.

Ichiba T, Teshima T, Kuick R, Misek DE, Liu C, Takada Y, Maeda Y, Reddy P, Williams DL, Hanash SM, Ferrara JL. Ichiba T, et al. Among authors: teshima t. Blood. 2003 Jul 15;102(2):763-71. doi: 10.1182/blood-2002-09-2748. Epub 2003 Mar 27. Blood. 2003. PMID: 12663442 Free article.

9

Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.

Clouthier SG, Cooke KR, Teshima T, Lowler KP, Liu C, Connolly K, Ferrara JL. Clouthier SG, et al. Among authors: teshima t. Biol Blood Marrow Transplant. 2003 Sep;9(9):592-603. doi: 10.1016/s1083-8791(03)00230-1. Biol Blood Marrow Transplant. 2003. PMID: 14506661 Free article.

10

The pathophysiology of acute graft-versus-host disease.

Ferrara JL, Cooke KR, Teshima T. Ferrara JL, et al. Among authors: teshima t. Int J Hematol. 2003 Oct;78(3):181-7. doi: 10.1007/BF02983793. Int J Hematol. 2003. PMID: 14604275 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,114 results

Search Page

Filters